Cell-based mRNA design and manufacturing platform producing pure, low-immunogenicity mRNA for next-generation therapeutics.
Sensible Biotechnologies is building the first cell-based mRNA therapeutics platform, using living cells as factories to produce highly stable mRNA with low immunogenicity that overcomes the limitations of conventional synthetic mRNA. Their approach enables scalable, cost-effective manufacturing of mRNA for therapeutic applications. The company targets the manufacturing challenges currently limiting the broader potential of mRNA medicines and positions their cell-based platform as enabling a new era of design-based biology. Sensible Biotechnologies is a product of Sensible Biotechnologies.